Wide Ranks

DYN

Dyne Therapeutics, Inc.

31.13

Top Statistics
Market Cap 3 B Forward PE -8.80 Revenue Growth 0.00 %
Current Ratio 17.02 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -7.89 Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 723 M Total Cash Per Share 7.11 Total Debt 24 M
Total Debt To Equity 3.52 Current Ratio 17.02 Book Value Per Share 6.93
All Measures
Short Ratio 994.00 % Message Board Id finmb_608699906 Fax 781 786 8866
Shares Short Prior Month 9 M Return On Equity -0.6868 City Waltham
Uuid bf98e34f-5989-3e23-b14d-e7c60952a6b7 Previous Close 29.23 First Trade Date Epoch Utc 1 B
Book Value 6.93 Beta 1.09 Total Debt 24 M
Volume 1 M Price To Book 4.49 Fifty Two Week Low 10.33
Total Cash Per Share 7.11 Shares Short Previous Month Date 1 B Target Median Price 50.00
Max Age 86400 Recommendation Mean 1.55 Sand P52 Week Change 0.3133
Target Mean Price 50.82 Net Income To Common -294513984 Short Percent Of Float 0.1185
Implied Shares Outstanding 101 M Trailing Peg Ratio None Last Fiscal Year End 1 B
Average Daily Volume10 Day 1 M Average Volume10days 1 M Total Cash 723 M
Next Fiscal Year End 1 B Held Percent Insiders 0.0048 Trailing PE 0.0000
Date Short Interest 1 B Most Recent Quarter 1 B Regular Market Previous Close 29.23
Target Low Price 34.00 Gmt Off Set Milliseconds -18000000 Fifty Day Average 31.89
Open 29.62 Free Cashflow -144041248 State MA
Dividend Yield 0.00 % Return On Assets -0.4035 Time Zone Short Name EST
Trailing Eps -3.58 Day Low 28.80 Address1 1560 Trapelo Road
Shares Outstanding 101 M Price Hint 2 Target High Price 66.00
Website https://www.dyne-tx.com 52 Week Change 1.81 Average Volume 1 M
Forward Eps -3.16 Recommendation Key buy Compensation As Of Epoch Date 1 B
Quick Ratio 1672.80 % Is_sp_500 False Regular Market Day High 31.32
Profit Margins 0.00 % Debt To Equity 3.52 Fifty Two Week High 47.45
Day High 31.32 Shares Short 10 M Regular Market Open 29.62
Industry Key biotechnology Earnings Growth 0.00 % Revenue Growth 0.00 %
Shares Percent Shares Out 0.0998 Operating Cashflow -243040000 Currency USD
Time Zone Full Name America/New_York Market Cap 3 B Is_nasdaq_100 False
Zip 02451 Quote Type EQUITY Industry Biotechnology
Long Name Dyne Therapeutics, Inc. Regular Market Day Low 28.80 Held Percent Institutions 1.12
Current Price 31.13 Enterprise To Ebitda -7.89 Financial Currency USD
Current Ratio 17.02 Industry Disp Biotechnology Number Of Analyst Opinions 11
Country United States Float Shares 74 M Two Hundred Day Average 32.49
Enterprise Value 2 B Forward PE -8.80 Regular Market Volume 1 M
Ebitda -312844000 Exchange NMS
Go to Yahoo Finance Go to Seeking Alpha 
Dyne Therapeutics, Inc., a clinical-stage muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States.

It is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics.

Dyne Therapeutics, Inc. was incorporated in 2017 and is headquartered in Waltham, Massachusetts.